Most cited papers from Viventia Bio (Canada)

Viventia Bio (Canada)

What are the most cited papers from Viventia Bio (Canada)?

The most cited paper from Viventia Bio (Canada) is "A Phase II Study of Oportuzumab Monatox: An Immunotoxin Therapy for Patients with Noninvasive Urothelial Carcinoma In Situ Previously Treated with Bacillus Calmette-Guérin" (Mark Marion Kowalski, Jacinthe Guindon, Louise Brazas et al., 2012), with 122 citations. Next come "Optimal Design Features of Camelized Human Single-domain Antibody Libraries" (79) and "Engineering and Biological Characterization of VB6-845, an Anti-EpCAM Immunotoxin Containing a T-cell Epitope-depleted Variant of the Plant Toxin Bouganin" (79).

Published TypeFieldAccess

Showing 39 of 39 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	A Phase II Study of Oportuzumab Monatox: An Immunotoxin Therapy for Patients with Noninvasive Urothelial Carcinoma In Situ Previously Treated with Bacillus Calmette-Guérin Mark Marion Kowalski, Jacinthe Guindon, Louise Brazas et al. · The Journal of Urology	19 Sep 2012	122
2	Optimal Design Features of Camelized Human Single-domain Antibody Libraries Jamshid Tanha, Ping Xu, Zhigang Chen et al. · Journal of Biological Chemistry Open access	2001	79
3	Engineering and Biological Characterization of VB6-845, an Anti-EpCAM Immunotoxin Containing a T-cell Epitope-depleted Variant of the Plant Toxin Bouganin Jeannick Cizeau, Danielle M. Grenkow, Jennifer G. Brown et al. · Journal of Immunotherapy	18 Jun 2009	79
4	A Phase I study of an intravesically administered immunotoxin targeting EpCAM for the treatment of nonmuscle-invasive bladder cancer in BCG-refractory and BCG-intolerant patients Macdonald, Mark Marion Kowalski, J. Entwistle et al. · Drug Design Development and Therapy Open access	Nov 2010	72
5	Rabies Control in Wild Carnivores Richard C. Rosatte, Rowland R. Tinline, David H. Johnston · Elsevier eBooks Book chapter	2007	48
6	A phase I clinical study of VB4-845: Weekly intratumoral administration of an anti-EpCAM recombinant fusion protein in patients with squamous cell carcinoma of the head and neck Maureen A. Spearman · Drug Design Development and Therapy Open access	Jun 2008	41
7	Fluorescence-guided tumor detection with a novel anti-EpCAM targeted antibody fragment: Preclinical validation Leonora S. F. Boogerd, Martin C. Boonstra, Hendrica A.J.M. Prevoo et al. · Surgical Oncology	23 Oct 2018	37
8	Effective tumor targeting: strategies for the delivery of Armed Antibodies. Glen C. MacDonald, Nick Glover · PubMed	Mar 2005	26
9	Molecular Simulation of Receptor Occupancy and Tumor Penetration of an Antibody and Smaller Scaffolds: Application to Molecular Imaging Kelly Davis Orcutt, Gregory Paul Adams, Anna M. Wu et al. · Molecular Imaging and Biology	17 Feb 2017	26
10	Trastuzumab-deBouganin Conjugate Overcomes Multiple Mechanisms of T-DM1 Drug Resistance Rachelle L. Dillon, Shilpa Chooniedass, Arjune Premsukh et al. · Journal of Immunotherapy	3 Mar 2016	25
11	Preclinical Evaluation of VB6-845: An Anti-EpCAM Immunotoxin with Reduced Immunogenic Potential Joycelyn Entwistle, Jennifer G. Brown, Shilpa Chooniedass et al. · Cancer Biotherapy and Radiopharmaceuticals	2 Aug 2012	25
12	A phase I clinical study of intratumorally administered VB4-845, an anti-epithelial cell adhesion molecule recombinant fusion protein, in patients with squamous cell carcinoma of the head and neck Glen C. MacDonald, Michèle Rasamoelisolo, J. Entwistle et al. · Medical Oncology	27 Oct 2008	24
13	Rabies Control in Wildlife David H. Johnston, Rowland R. Tinline · Elsevier eBooks Book chapter	2003	19
14	Development of a GMP Phase III purification process for VB4-845, an immunotoxin expressed in E. coli using high cell density fermentation Arjune Premsukh, Joelle M. Lavoie, Jeannick Cizeau et al. · Protein Expression and Purification	28 Mar 2011	16
15	Preclinical Assessment of an Anti-EpCAM Immunotoxin: Locoregional Delivery Provides a Safer Alternative to Systemic Administration Jennifer G. Brown, Michèle Rasamoelisolo, Maureen A. Spearman et al. · Cancer Biotherapy and Radiopharmaceuticals	Aug 2009	16
16	Single-dose pharmacokinetic study of rapidly dispersing diclofenac potassium formulations in healthy volunteers Michael Lissy, Dwight D. Stiff, Mark Marion Kowalski et al. · Current Medical Research and Opinion	10 Aug 2009	12
17	DeBouganin Diabody Fusion Protein Overcomes Drug Resistance to ADCs Comprised of Anti-Microtubule Agents Shilpa Chooniedass, Rachelle L. Dillon, Arjune Premsukh et al. · Molecules Open access	17 Dec 2016	10
18	Rapid imaging of human melanoma xenografts using an scFv fragment of the human monoclonal antibody H11 labelled with 111In R. M. REILLY, Paramita Maiti, Reza Kiarash et al. · Nuclear Medicine Communications	May 2001	10
19	The Preclinical and Clinical Evaluation of VB6-845: An Immunotoxin with a De-Immunized Payload for the Systemic Treatment of Solid Tumors Joycelyn Entwistle, Mark Marion Kowalski, Jennifer G. Brown et al. Book chapter	2 Nov 2012	10
20	Immunofluorescence imaging as a tool for studying the pharmacokinetics of a human monoclonal single chain fragment antibody Bram Ramjiawan, Robert E. Ariano, Henry Horst Mantsch et al. · IEEE Transactions on Medical Imaging	Oct 2002	9
21	Impact of Fc N-linked glycans on in vivo clearance of an immunoglobulin G1 antibody produced by NS0 cell line Jun Kim, Haibin Luo, Wendy I. White et al. · mAbs Open access	2020	8
22	Fusogenics: A Recombinant Immunotoxin-Based Screening Platform to Select Internalizing Tumor-Specific Antibody Fragments Jeannick Cizeau, Marianne G.P. Torres, Sharla G. Cowling et al. · SLAS DISCOVERY Open access	4 Dec 2010	6
23	A targeted proteomic approach for the identification of tumor-associated membrane antigens using the ProteomeLab™ PF-2D in tandem with mass spectrometry Francina C. Chahal, Joycelyn Entwistle, Nick Glover et al. · Biochemical and Biophysical Research Communications	8 Aug 2006	6
24	Human Leukocyte Antigen–Presented Macrophage Migration Inhibitory Factor Is a Surface Biomarker and Potential Therapeutic Target for Ovarian Cancer Andrea M. Patterson, Saghar Kaabinejadian, Curtis McMurtrey et al. · Molecular Cancer Therapeutics Open access	31 Dec 2015	5
25	In vivo monitoring of the distribution of a monoclonal antibody fragment Bram Ramjiawan, Pradip Kumar Maiti, Howard A. Kaplan et al. · Vibrational Spectroscopy	Feb 2002	4
26	Population Structure of Harvested Red Foxes (Vulpes vulpes) and Coyotes (Canis latrans) on Prince Edward Island, Canada Wendela Wapenaar, Fiep de Bie, David H. Johnston et al. · The Canadian Field-Naturalist Open access	22 Apr 2013	4
27	Evaluation Of Infusion Reactions And Infusion Times In The N-Momentum Study Of Inebilizumab For NMOSD (1941) Mark J. Tullman, Jack Ratchford, Dewei She et al. · Neurology	13 Apr 2021	3
28	Long-term Efficacy and Safety of Inebilizumab for Neuromyelitis Optica Spectrum Disorder in the Randomized, Double-blind N-MOmentum Study and Extension (3998) Bruce Cree et al. · Neurology	14 Apr 2020	3
29	Long Term Efficacy Outcomes with Inebilizumab Treatment in NMOSD: the N-MOmentum Trial (2329) Bruce Cree, Jeffrey L. Bennett, Brian G. Weinshenker et al. · Neurology	13 Apr 2021	3
30	Inebilizumab Treatment Reduces The Occurrence Of Pain In NMOSD Patients (2319) Ho Jin Kim, Michael Robert Smith, Eliezer Katz et al. · Neurology	13 Apr 2021	3
31	Long Term Safety Outcomes with Inebilizumab Treatment in NMOSD: the N-MOmentum Trial (2283) Bruce Cree, Jeffrey L. Bennett, Brian G. Weinshenker et al. · Neurology	13 Apr 2021	2
32	Serum Neurofilament Light Chain Levels (sNfL) Correlate Best with Attack-related Disability in Neuromyelitis Optica (4105) O. Atkas et al. · Neurology	14 Apr 2020	1
33	VB1-008: Identification of a fully-human antibody specific for CD44E and CD44-isoform-3 Jeannick Cizeau, Francina C. Chahal, Joycelyn Entwistle et al. · Cancer Research	15 Apr 2006	1
34	Pre-clinical safety assessment of VB4-845, an EpCAM binding immunoconjugate Crystal Marlin, Jennifer G. Brown, Michele Rasamoelisoloa et al. · Cancer Research	May 2008	1
35	Electrophysiological monitoring of plants: an exploratory study on drought stress Raffaele Zappalà, Lorenzo Gavazzeni, Matteo Gandolfi et al. · bioRxiv (Cold Spring Harbor Laboratory) PreprintOpen access	7 Dec 2025	0
36	Familial Monophasic Acute Transverse Myelitis Due to a Pathogenic Variant in VPS37A (224) Michael Levy, Maureen A. Mealy, Tai‐Seung Nam et al. · Neurology	14 Apr 2020	0
37	Pharmacodynamic modeling and exposure-response assessment of inebilizumab in subjects with neuromyelitis optica spectrum disorders (1872) Yan Li, Bing Wang, Dewei She et al. · Neurology	13 Apr 2021	0
38	VB6-845: recombinant engineering of an Ep-CAM-specific Fab antibody for optimal delivery of de-immunized bouganin (de-bouganin) Jeannick Cizeau, Denis G. Bosc, Joycelyn Entwistle et al. · Cancer Research	May 2005	0
39	Complete regression of ovarian cancer xenografts following treatment with the recombinant immunocytotoxic protein, VB6-845. Jennifer G. Brown, Michèle Rasamoelisolo, Jeannick Cizeau et al. · Cancer Research	15 Apr 2006	0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.